Tech Center 1600 • Art Units: 1600 1642 1648 1671 1675
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18344952 | METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE | Final Rejection | Abbott Laboratories |
| 18560515 | Coronavirus Constructs and Vaccines | Non-Final OA | The Regents of the University of California |
| 17800687 | Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors | Non-Final OA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 18021719 | RAPID AND LOW-COST NUCLEIC ACID DETECTION USING TRANSLATION-BASED SEQUENCE VERIFICATION ASSAYS | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18016932 | METHODS OF DIAGNOSTICS | Non-Final OA | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
| 18415814 | METHOD OF DETECTING SARS-COV IN A SAMPLE | Non-Final OA | Imam Abdulrahman Bin Faisal University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy